NCT01388309View on ClinicalTrials.gov

An Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs

CompletedOBSERVATIONAL
Enrollment

64

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Rheumatoid Arthritis
Trial Locations (4)

975 17

Banská Bystrica

826 06

Bratislava

04011

Košice

921 12

Piešťany

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01388309 - An Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs | Biotech Hunter | Biotech Hunter